Smith Group Asset Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Smith Group Asset Management, LLC
- $1.36 Trillion
- Q4 2024
Shares
2 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$335 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$326 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$323 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$275 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$264 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.01B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...